| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
49,459 |
41,621 |
$3.22M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,721 |
5,696 |
$484K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,601 |
5,335 |
$442K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
23,138 |
22,297 |
$326K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,411 |
7,175 |
$302K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,474 |
3,471 |
$291K |
| 99442 |
|
3,622 |
3,288 |
$255K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,735 |
1,735 |
$157K |
| 92587 |
|
4,104 |
4,100 |
$114K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
719 |
709 |
$75K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
550 |
550 |
$50K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,110 |
8,706 |
$39K |
| 90461 |
|
1,642 |
1,632 |
$27K |
| 99381 |
|
303 |
303 |
$27K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,230 |
637 |
$15K |
| 92567 |
|
1,327 |
1,326 |
$13K |
| 99383 |
|
107 |
107 |
$11K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
838 |
816 |
$8K |
| 69210 |
|
180 |
175 |
$6K |
| 94667 |
|
833 |
811 |
$6K |
| 99384 |
|
44 |
44 |
$5K |
| 94664 |
|
835 |
813 |
$4K |
| 99173 |
|
6,409 |
6,394 |
$3K |
| 81002 |
|
1,417 |
1,379 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
30 |
30 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
76 |
74 |
$2K |
| 36400 |
|
97 |
92 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
3,401 |
3,372 |
$1K |
| 99382 |
|
12 |
12 |
$1K |
| 90670 |
|
1,964 |
1,961 |
$891.88 |
| 90651 |
|
111 |
111 |
$840.92 |
| 99441 |
|
16 |
15 |
$707.27 |
| A7015 |
Aerosol mask, used with dme nebulizer |
734 |
714 |
$568.90 |
| 0071A |
|
14 |
14 |
$490.28 |
| 90716 |
|
898 |
898 |
$472.27 |
| 90686 |
|
3,162 |
3,155 |
$452.44 |
| 96127 |
|
80 |
80 |
$353.11 |
| 90710 |
|
398 |
398 |
$333.19 |
| 90677 |
|
452 |
452 |
$288.91 |
| 90655 |
|
56 |
56 |
$265.44 |
| 90744 |
|
1,574 |
1,573 |
$244.67 |
| 90707 |
|
376 |
376 |
$221.09 |
| 90633 |
|
1,713 |
1,712 |
$182.26 |
| 90656 |
|
335 |
335 |
$180.34 |
| 36416 |
|
3,862 |
3,785 |
$157.88 |
| 99072 |
|
1,542 |
1,359 |
$154.80 |
| 90734 |
|
137 |
137 |
$146.62 |
| 90713 |
|
992 |
990 |
$100.00 |
| 90700 |
|
1,517 |
1,515 |
$50.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
204 |
198 |
$30.66 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
14 |
14 |
$30.18 |
| 90672 |
|
98 |
98 |
$26.88 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
577 |
564 |
$22.01 |
| 90698 |
|
829 |
827 |
$17.85 |
| 90619 |
|
472 |
472 |
$0.16 |
| 90671 |
|
31 |
31 |
$0.02 |
| 90715 |
|
378 |
378 |
$0.02 |
| 90685 |
|
120 |
120 |
$0.01 |
| 90681 |
|
76 |
76 |
$0.00 |
| 91300 |
|
12 |
12 |
$0.00 |
| 99000 |
|
686 |
674 |
$0.00 |
| 90647 |
|
1,306 |
1,305 |
$0.00 |
| 90696 |
|
323 |
323 |
$0.00 |
| 3008F |
|
912 |
908 |
$0.00 |
| 90680 |
|
285 |
284 |
$0.00 |
| 90660 |
|
32 |
32 |
$0.00 |
| 90657 |
|
93 |
93 |
$0.00 |